Considered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hamps Bio Ltd's board, meeting on February 14, 2026, approved acquiring 100% of paid-up equity in HSDL Innovative Private Limited for a cash purchase price of about ₹2.04 crore. Post-acquisition, HSDL Innovative will become a wholly-owned subsidiary (WOS) of Hamps Bio. The target is in the freeze-drying food business (fruits, vegetables, herbs, ready-to-eat foods), with an FY25 turnover of around ₹1.87 crore (FY24: ₹1.85 crore; FY23: ₹1.45 crore). The deal is a related-party transaction since Hamps Bio's promoters hold shares in the target. The deal is expected to close within 60 days, with no government approvals required.
For shareholders, this is a relatively small, bolt-on acquisition aimed at consolidating the freeze-drying food business under Hamps Bio. While it deepens the company's presence in this niche, the ~₹2 crore deal size is modest compared to typical operating scale, so immediate impact on stock price is likely limited — though sentiment may improve if synergies materialize.